31results about How to "Variability" patented technology

There is here disclosed a technique which can improve mechanical properties such as strength and impact resistance of molded articles without noticeably changing molding materials and rebuilding a molding apparatus. In a molding method in which the molding materials are fed to a mold disposed at one end of a cylinder while the molding materials in the cylinder are molten and kneaded, the molding materials can be molded while vibration is applied to the molding materials in a direction crossing a flow direction of the resin material at right angles. The vibration does not have to possess any node portion on a surface which contacts the molding material.

Disclosed is a field effect transistor including an insulating film disposed between a source / drain region and a substrate. Since the insulating film prevents current leakage under a channel, it is not necessary to form a punch-through stopper. Further disclosed is a method of forming a field effect transistor.

Radiotracer vorozole compounds for in vivo and in vitro assaying, studying and imaging cytochrome P450 aromatase enzymes in humans, animals, and tissues and methods for making and using the same are provided. [N-radio-methyl] vorozole substantially separated from an N-3 radio-methyl isomer of vorozole is provided. Separation is accomplished through use of chromatography resins providing multiple mechanisms of selectivity.

There is provided an optical-fiber connector endface inspection microscope system comprising optical power measurement capability, wherein optical power measurement is provided via an optical power meter device implemented within an extension unit positioned along an optical path between the inspected optical-fiber connector endface and the optical-fiber connector endface inspection microscope, i.e. between the inspected optical-fiber connector endface and objective optics of the optical-fiber connector endface inspection microscope.

The invention discloses specific primer sequences that can be used in DNA molecular marker methods for differentiating different fish, including upstream primers and downstream primers. Using the specific primer sequences to identify different fish DNA molecular marker methods includes: first according to known 5S of fish? Design specific primers for the conserved coding region sequence of the rDNA gene; then extract the genome of the fish material to be identified; use the genomic DNA as a template to design a PCR reaction system to amplify its 5S? rDNA gene, using 5S? After the polymorphism of the non-transcribed spacer region of the rDNA gene was purified by PCR amplification reaction, agarose gel electrophoresis and DNA gel recovery kit, the sample 5S? The DNA fragment pattern of the rDNA gene; finally, the species of the fish material to be identified was determined by comparing the DNA fragment pattern in the gel imaging with the known fish. The method of the invention has the advantages of quickness, accuracy, easy operation and the like.

Embodiments of the present invention relate to a non-invasive stimulatory adjustment of the body's own self-repair-system using a plurality of electrons. In particular, embodiments of the present invention relate to a plurality of electrons for use in the restoration of a patient's health, preferably a human patient's health in a number of medical conditions. Moreover, embodiments of the present invention relate to a method of treatment using a plurality of electrons for use in the restoration of a patient's health, preferably a human patient's health. Moreover, embodiments of the present invention relate to a method of stimulatory adjustment of the body's own self-repair system using a plurality of electrons.

According to the invention, there is provided a solid pharmaceutical composition formulation for nasal delivery of an opioid antagonist, comprising a pharmacologically-effective amount of an opioid antagonist and a pharmaceutically-acceptable carrier. Said compositions are preferably in the form of a powder produced by spray-drying, which are subsequently loaded into single use nasal applicators. Preferred pharmaceutically-acceptable carriers in this regard include disaccharides (e.g. lactose or trehalose) and dextrins (e.g. cyclodextrins or maltodextrins), preferably spray-dried together in combination. Compositions may further comprise an alkyl saccharide, preferably a sucrose ester, such as sucrose monolaurate. Said compositions and applicators may be employed in the treatment of opioid overdose in subjects.

Provided are methods of immunizing a viewport of a medical device against fogging before or during a medical procedure, and related apparatuses and devices. The methods comprise applying plasma to the viewport prior to use, thereby rendering a surface of the viewport highly hydrophilic. The methods eliminate or at least significantly reduce blur due to fogging.